Diabetes control in older people

BMJ (Online)

Volumn 346, Issue 7905, 2013, Pages

  McLaren, Laura A ^a   Quinn, Terence J ^b   McKay, Gerard A ^a  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

COGNITIVE DEFECT; COMORBIDITY; DIABETES CONTROL; DISEASE ASSOCIATION; EDITORIAL; ELDERLY CARE; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; LIFE EXPECTANCY; MENTAL HEALTH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRACTICE GUIDELINE; PRIORITY JOURNAL;

AGED; BLOOD GLUCOSE; DIABETES MELLITUS; HUMANS; PATIENT EDUCATION AS TOPIC; SELF CARE; SOCIOECONOMIC FACTORS;

EID: 84877586819     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f2625     Document Type: Editorial

References (12)

1. Kirkman MS, Bridscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. Diabetes in older adults. A consensus report from the American Diabetes Association and the American Geriatrics Society. Diabetes Care 2012;35:2650-64.
2. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, et al. Management of hyperglycaemia in type 2 diabetes. A consensus algorithm for the initiation and adjustment of therapy. A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2006;29:963-72.
3. British Geriatrics Society. Best practice guide 6.4: Diabetes. 2009.
4. Sinclair AJ, Paolisso G, Castro M, Bourdel-Marchasson I, Gadsby R, Rodriguez Mañas L, et al. European Diabetes Working Party for Older People 2011. Clinical guidelines for type 2 diabetes. Executive summary. Diabetes Metab 2011;37:S27-38.
5. National Diabetes Audit 2010-2011. 2012.
6. Gerstein HC, Miller ME, Byington RP, Byington RP, Goff DC Jr, Bigger JT, et al; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008;358:2545-59. (Pubitemid 351831356)
7. Patel A, MacMahon S, Chalmers J, Neal B, Billot L, Woodward M, et al; ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med 2008;358:2560-72. (Pubitemid 351831357)
8. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al; VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009;360:129-39.
9. Munshi MN, Segal AR, Suhl E, Staum E, Desrochers L, Sternthal A, et al. Frequent hypoglycaemia among elderly patients with poor glycaemia control. Arch Intern Med 2011, 171:362-4.
10. Nauck MA, Meininger G, Sheng D, Terranella L, Stein PP, Tesone P, et al. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial. Diabetes Obes Metab 2007;9:194-205. (Pubitemid 46206563)
11. Monami M, Marchionni N, Mannucci E. Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials. Eur J Endocrinol 2009;160:909-17.
12. Strojek K, Yoon KH, Hruba V, Elze M, Langkilde AM, Parikh S. Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with glimepiride: a randomized, 24-week, double-blind, placebo-controlled trial. Diabetes Obes Metab 2011;13:928-38.